Cover Image

Synergistic Activity of Equol and Meropenem against Carbapenem-Resistant <i>Escherichia coli</i>

The emergence of carbapenem-resistant <i>Enterobacterales</i> (CRE) seriously limits treatment options for bacterial infections. Combined drugs are an effective strategy to treat these resistant strains. This study aimed to evaluate the synergistic effect of equol and meropenem against c...

Full description

Saved in:

Bibliographic Details
Main Authors:	Hye-Rim Kim (Author), Yong-Bin Eom (Author)
Format:	Book
Published:	MDPI AG, 2021-02-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Fingolimod Promotes Antibacterial Effect of Doripenem against Carbapenem-Resistant <i>Escherichia coli</i>
by: Hye-Won Jin, et al.
Published: (2022)

Synergistic Antibacterial Effects of Meropenem in Combination with Aminoglycosides against Carbapenem-Resistant <i>Escherichia coli</i> Harboring <i>bla</i><sub>NDM-1</sub> and <i>bla</i><sub>NDM-5</sub>
by: Pawarisa Terbtothakun, et al.
Published: (2021)

Pharmacokinetic/Pharmacodynamic (PK/PD) Simulation for Dosage Optimization of Colistin Against Carbapenem-Resistant <i>Klebsiella pneumoniae</i> and Carbapenem-Resistant <i>Escherichia coli</i>
by: Kamonchanok Jitaree, et al.
Published: (2019)

Synergistic Activity of Tetrandrine and Colistin against <i>mcr-1</i>-Harboring <i>Escherichia coli</i>
by: Muhammad Shafiq, et al.
Published: (2022)

In Vitro Synergy of Colistin in Combination with Meropenem or Tigecycline against Carbapenem-Resistant <i>Acinetobacter baumannii</i>
by: Jacinda C. Abdul-Mutakabbir, et al.
Published: (2021)

Clinical Outcomes and Safety of Meropenem-Colistin versus Meropenem-Tigecycline in Patients with Carbapenem-Resistant <i>Acinetobacter baumannii</i> Pneumonia
by: Jae-Min Park, et al.
Published: (2021)

Deciphering the Crucial Roles of the Quorum-Sensing Transcription Factor SdiA in NADPH Metabolism and (<i>S</i>)-Equol Production in <i>Escherichia coli</i> Nissle 1917
by: Zhe Wang, et al.
Published: (2024)

Synergistic Effect of Propolis and Antibiotics on Uropathogenic <i>Escherichia coli</i>
by: Jean-Philippe Lavigne, et al.
Published: (2020)

Drug Susceptibility Testing and Synergistic Antibacterial Activity of Curcumin with Antibiotics against Enterotoxigenic <i>Escherichia coli</i>
by: Rangel-Castañeda Itzia Azucena, et al.
Published: (2019)

Emergence and mechanism of carbapenem-resistant Escherichia coli in Henan, China, 2014
by: Wen-juan Liang, et al.
Published: (2018)

In Vitro Synergistic Activity of Antimicrobial Combinations against Carbapenem- and Colistin-Resistant <i>Acinetobacter baumannii</i> and <i>Klebsiella pneumoniae</i>
by: Paraskevi Mantzana, et al.
Published: (2023)

Activity of carbapenems and tigecycline against ESBL-producing Escherichia coli and Klebsiella spp.
by: Caio Fernando de Oliveira, et al.
Published: (2018)

Comparative In Vitro Activity of Ceftazidime-Avibactam, Imipenem-Relebactam, and Meropenem-Vaborbactam against Carbapenem-Resistant Clinical Isolates of <i>Klebsiella pneumoniae</i> and <i>Pseudomonas aeruginosa</i>
by: Anthony Sophonsri, et al.
Published: (2024)

Evaluation of In Vitro Activity of Double-Carbapenem Combinations against KPC-2-, OXA-48- and NDM-Producing <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i>
by: Lisa Allander, et al.
Published: (2022)

Effect of Glycerol on Fosfomycin Activity against <i>Escherichia coli</i>
by: Miriam Ortiz-Padilla, et al.
Published: (2022)

Evaluation of the Synergistic Antibacterial Effects of Fosfomycin in Combination with Selected Antibiotics against Carbapenem-Resistant <i>Acinetobacter baumannii</i>
by: Ozioma F. Nwabor, et al.
Published: (2021)

The synergistic activity of SBC3 in combination with Ebselen against Escherichia coli infection
by: Hao Chen, et al.
Published: (2022)

Challenging T > MIC Using Meropenem vs. Escherichia coli and Pseudomonas aeruginosa
by: A. Nussbaumer-Pröll, et al.
Published: (2022)

Synergistic Activity of Pep16, a Promising New Antibacterial Pseudopeptide against Multidrug-Resistant Organisms, in Combination with Colistin against Multidrug-Resistant <i>Escherichia coli</i>, In Vitro and in a Murine Peritonitis Model
by: Samuel Chosidow, et al.
Published: (2023)

Antibacterial Activity of Bacteriocinogenic Commensal <i>Escherichia coli</i> against Zoonotic Strains Resistant and Sensitive to Antibiotics
by: Justyna Mazurek-Popczyk, et al.
Published: (2020)

Structure-Activity Relationships of Cationic Lipidoids against <i>Escherichia coli</i>
by: James Jennings, et al.
Published: (2023)

Synergy between Florfenicol and Aminoglycosides against Multidrug-Resistant <i>Escherichia coli</i> Isolates from Livestock
by: Shukho Kim, et al.
Published: (2020)

Exogenous glutathione reverses meropenem resistance in carbapenem-resistant Klebsiella pneumoniae
by: Juan Yi, et al.
Published: (2023)

Characterization of the Antimicrobial Activities of <i>Trichoplusia ni</i> Cecropin A as a High-Potency Therapeutic against Colistin-Resistant <i>Escherichia coli</i>
by: Hyeju Lee, et al.
Published: (2023)

Temporal Variation of Meropenem Resistance in <i>E. coli</i> Isolated from Sewage Water in Islamabad, Pakistan
by: Saba Yasmin, et al.
Published: (2022)

Carvacrol Silver Nanoparticles - An Effective Antibacterial Against Carbapenem-Resistant Acinetobacter Isolates Unaided and With Meropenem
by: Soha Haque, et al.
Published: (2024)

ESBL-Producing, Carbapenem- and Ciprofloxacin-Resistant <i>Escherichia coli</i> in Belgian and Dutch Broiler and Pig Farms: A Cross-Sectional and Cross-Border Study
by: Sien De Koster, et al.
Published: (2021)

Antimicrobial Resistance in Commensal <i>Escherichia coli</i> of the Porcine Gastrointestinal Tract
by: Lorcan O'Neill, et al.
Published: (2023)

Antimicrobial Resistance in Diverse <i>Escherichia coli</i> Pathotypes from Nigeria
by: Kenneth Nnamdi Anueyiagu, et al.
Published: (2024)

Activity of Synthetic Peptide KP and Its Derivatives against Biofilm-Producing <i>Escherichia coli</i> Strains Resistant to Cephalosporins
by: Lorenza Artesani, et al.
Published: (2024)

Enhancing Colistin Activity against Colistin-Resistant <i>Escherichia coli</i> through Combination with Alginate Nanoparticles and Small Molecules
by: Noura Hazime, et al.
Published: (2022)

Antimicrobial Resistance of <i>Escherichia coli</i> for Uncomplicated Cystitis: Korean Antimicrobial Resistance Monitoring System
by: Seong Hyeon Yu, et al.
Published: (2024)

Clinically Relevant Concentrations of Polymyxin B and Meropenem Synergistically Kill Multidrug-Resistant <i>Pseudomonas aeruginosa</i> and Minimize Biofilm Formation
by: Hasini Wickremasinghe, et al.
Published: (2021)

<i>Escherichia coli</i> Recent Advances on Physiology, Pathogenesis and Biotechnological Applications
Published: (2017)

iEquol an isoflavonoid: potential for improved prostate health, <it>in vitro </it>and <it>in vivo </it>evidence
by: Hamaker Amy N, et al.
Published: (2011)

Antimicrobial Activity of Essential Oils Evaluated In Vitro against <i>Escherichia coli</i> and <i>Staphylococcus aureus</i>
by: Michela Galgano, et al.
Published: (2022)

Efficacy of Novel Bacteriophages against <i>Escherichia coli</i> Biofilms on Stainless Steel
by: Jean Pierre González-Gómez, et al.
Published: (2021)

Anti-Biofilm Effect of Bacteriophages and Antibiotics against Uropathogenic <i>Escherichia coli</i>
by: Laima Mukane, et al.
Published: (2022)

Genome-Wide Screening of Oxidizing Agent Resistance Genes in <i>Escherichia coli</i>
by: Hao Chen, et al.
Published: (2021)

Insights into Emergence of Antibiotic Resistance in Acid-Adapted Enterohaemorrhagic <i>Escherichia coli</i>
by: Salma Waheed Sheikh, et al.
Published: (2021)